GEN6050X
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GEN6050X, covering 2025-07-29 to 2025-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy. [EARLY_Phase 1]